In this review
Choose a service with a defined purpose
LaSara’s catalogue spans weight care, testosterone and other hormone services, sexual health and products marketed for aging. That can be convenient for comparing services. It does not establish a complete preventive examination, a shared laboratory package or improvement in healthy lifespan. Each prescription still needs its own clinical reason. [1] [2]
The weight-care pages describe one-to-one metabolic-health support and continuing clinical check-ins. Those are specific service features. They should not be silently attached to every NAD+ or sermorelin purchase, nor treated as proof that adding more therapies improves health. [3]
Separate a health measurement from a meaningful outcome with the biological-age testing evidence.
The supply period changes the purchase
NAD+ injection has $248 subscription options labelled one or two months, alongside separate $150, $275 and $375 one-, two- and three-month plan cards. Sermorelin injection subscriptions are $242 for six weeks, $449 for twelve and $719 for eighteen, while its vial description refers to ten weeks. Obtain a consistent delivery and renewal schedule for the chosen preparation. [4] [5]
Nasal products are separately priced and specified. The NAD+ page’s longer week-based plans do not match its one-month bottle description; the sermorelin nasal page explicitly qualifies absorption evidence. Route convenience, total content and treatment benefit are different comparisons. [6] [7]
Align preparation, supplied period and payments in the health-service cost planner.
Continuing care needs named inclusions
Current weight-care subscriptions are $289 monthly for compounded semaglutide and $379 for compounded tirzepatide. About-page semaglutide pricing starts at $179, without explaining how that teaser maps to current product cards. A complete quote should identify the preparation, selected supply and clinical service before a monthly number is compared. [2] [8] [9]
Tirzepatide describes monthly delivery, proactive check-ins and laboratory monitoring. That wording does not establish the actual included tests or collection fees. About-page product-specialist support and metabolic-health coaching are useful access descriptions, but do not specify every appointment or replace the treating clinician’s monitoring plan. [2] [9]
Compare another prescription and testing arrangement in our YOURx service-scope review.
Compare another provider’s stated supply and cancellation agreement in our Nova MD plan-and-terms review.
A pause promise cannot answer every exit question
Product pages advertise cancellation or a pause anytime. The public Terms & Conditions cover website use rather than a complete medication-order refund policy. Confirm the cancellation cutoff, non-approval handling, shipment remedies and repeating charge before a long commitment. The same national telehealth description does not establish every product’s eligibility in every state. [4] [5] [10]
Compounded drugs are not FDA-approved. I would choose LaSara for a defined service with an understandable supply and follow-up agreement, rather than buy several products around an anti-aging theme. More treatment categories do not establish more healthy years. [11]
For a service with more detailed public purchase terms, read the Telezen MD commitment review.
Understanding the cost
No single healthspan package price. Current NAD+ injection has $248 subscription options and separate $150/$275/$375 plan cards; sermorelin injection subscriptions $242/$449/$719 by labelled period. GLP-1 subscriptions separately $289 semaglutide/$379 tirzepatide monthly. Confirm actual selected supply, tests, fees and renewal.
Build your cost estimateSources
- LaSara: current prescription and wellness catalogue
- LaSara: subscription teaser, coaching, shipping and service catalogue
- LaSara: weight-care support and coaching model
- LaSara: NAD+ injection plans and stated vial specification
- LaSara: sermorelin injection pricing and supply descriptions
- LaSara: NAD+ nasal plan totals, monthly annotations and bottle duration
- LaSara: sermorelin nasal plan and route-specific evidence qualification
- LaSara: compounded semaglutide plan totals and included clinical support
- LaSara: compounded tirzepatide plans, check-ins and laboratory-monitoring description
- LaSara: public website terms and national telehealth description
- FDA: compounded drugs and premarket approval limits
This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.